Ampath and Innocent Hearts Hospital Partner to expand diagnostic services

India Pharma Outlook Team | Wednesday, 16 October 2024

 diagnostic services, latest technology

American Institute of Pathology & Laboratory Sciences Pvt Ltd (Ampath) in collaboration with Innocent Hearts Superspeciality Hospital expands its diagnostic services in Jalandhar with the launch of a new state-of-the-art pathology laboratory. This facility marks Ampath's continued commitment to providing high-quality, comprehensive diagnostic services across India.  

The new laboratory in Jalandhar is equipped with the latest technology With a menu of more than 2,500 tests, including clinical biochemistry, hematology, flow cytometry, clinical pathology, serology, immunology, microbiology, cytology, histopathology, immunohistochemistry, molecular diagnosis, NGS, and cytogenetics, the lab is poised to deliver precise and timely diagnostic results.  

Harish Trivedi, CEO, CTSI – South Asia, stated  “Expanding into Jalandhar marks a significant milestone for Ampath Labs. We are thrilled to introduce our comprehensive range of diagnostic services to this region, providing residents with access to top-tier healthcare diagnostics. This expansion not only reflects our commitment to delivering high-quality, reliable diagnostic services but also underscores our dedication to supporting better health outcomes in the community. We believe that with our advanced technology and skilled professionals, we can make a meaningful impact on the healthcare landscape in Jalandhar and surrounding areas, offering patients the best in diagnostic care."   Dr Maneesh Bagai, chief operating officer,  Ampath Labs, said, "This expansion aligns perfectly with our vision of making high-quality diagnostic services accessible across India, enabling better healthcare outcomes for all. Our lab in Jalandhar will serve the local community with advanced diagnostic tests, maintaining our high standards of accuracy and efficiency."

© 2024 India Pharma Outlook. All Rights Reserved.